throbber

`

`
`
`CLINICAL MICROBIOLOGY REVIEWS
`
`
`
`VOLUME 11 0 JULY 1998 0 NUMBER 3
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Lynne S. Garcia, Editor (2002)
`
`
`
`UCLA Medical Center
`
`
`
`Los Angcies, Calif.
`
`
`
`
`
`
`
`
`Betty A. Forbes, Editor in Chief (2002)
`SUNY Heaitii Science Center
`
`
`
`
`
`
`Syracuse, NY.
`
`
`
`
`
`
`Kenneth D. Thompson, Editor (2002)
`
`
`
`
`
`Universint of Chicago Medicai Center
`
`
`Chicago, Iii.
`
`
`
`
`
`
`Judith E. Domer (1999}
`
`
`
`Kevin Hazen (1998)
`
`
`EDITORIAL BOARD
`
`
`
`
`
`
`
`J. Michael Miller (2000)
`
`
`
`Andrew Under-dank (2000)
`
`
`
`
`Daniel F. Sahm (1998}
`
`
`
`
`
`Steven C. Specter (2000)
`
`
`
`
`Gregory A. Starch (1998)
`
`
`
`
`Barbara H. lglewski, Chairman. Publications Board
`
`
`
`
`
`
`
`
`Linda M. lllig, Director: Journals
`
`
`
`
`
`
`
`Beverley .1. Bennett, Production Editor
`
`
`
`
`Victoria A. Cohen, Assistant Production Editor
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Ciinicai Microbioiogv Reviews considers for publication both solicited and unsolicited reviews and monographs deaiing with oil aspects
`of ciinicai microbioiogy. Manuscripts. proposais, and conespondencc regarding editoriat' matters should be addressed to the Editor in
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Chief; Betty/4. Forbes, Department of Clinical Pathoiog’. SUNY Health Science Center. 750 East Adams St., Syracuse, NY 13210-2339.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Ciinicai Microbioiogor Reviews (ISSN 0893-8512) is published quarterly (January, April, July, and October). one volume per year,
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`by the American Society for Microbiology (ASM). Nonmember print subscription prices (per year) are: $146. US; $150, Canada
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`(plus 'r'% GST, or 7% GST + 8% HST where applicable); $168, Europe; $169, Latin America; $170, rest of world. Member print
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`subscription prices (per year) are: $40, U.S.; $43, Canada (plus 'i% CST, or 7% GST + 8% HST when: applicable); $53, Europe;
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`$54, Latin America; $55, rest of world. Singles copies are: $47, nonmember; $15, member (Canadians add 7% GST, or 7% GST
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`+ 8% HST where applicable). For prices of CD-ROM versions, contact the Subscriptions Unit. ASM. CorreSpondence relating
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`to subscriptions, defective copies. missing issues, and availability of back issues should be directed to the Subscriptions Unit, ASM;
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`correspondence relating to reprint orders should be directed to the Reprint Order Unit, ASM; and correspondence relating to
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`disposition of submitted manuscripts, proofs, and general editorial matters should be directed to the Journals Department,
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`American Society for Microbiology. 1325 Massachusetts Ave, N.W.. Washington, DC 20005—4171. Phone: (202) 737-3600.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Claims for missing issues from residents of the United States, Canada, and Mexico must be submitted within 3 months after
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`publication of the issues; residents of all other countries must submit claims within 6 months of publication of the issues. Claims
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`for issucs missing because of failure to report an address change or for issues “missing from files" will not be allowed.
`
`
`
`
`CODEN: CMIREX
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Periodicals postage paid at Washington. DC 20005, and at additional mailing offices.
`
`
`
`
`
`
`
`
`
`
`
`
`POSTMASTER: Send address changes to Clinical Microbiology Reviews, ASM, 1325 Massachusetts Ave, N.W., Washington, DC
`
`
`
`20005-4171.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Made in the United States of America. Printed on acid-free paper.
`
`
`
`
`
`
`
`
`
`COpyright © 1998, American Society for Microbiology.
`
`
`
`
`
`All Rights Reserved.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`The code at the top of the first page of an article in this journal indicates the copyright owner‘s consent that copies of the article
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`may be made for personal use or for personal use of specific clients. This consent is given on the condition. however, that the copier
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`pay the stated pct-copy fee through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923. for copying
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`beyond that permitted by Sections 107 and 108 of the US. Copyright Law. This consent does not extend to other kinds of copying,
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`such as copying for general distribution, for advertising or promotional purposes, for creating new collective works, or for resale.
`
`Page 2 of 17
`
`Page 2 of 17
`
`

`

`I
`to.
`ICAL MICROBIOLOGY REVIEWS. July 1998. p. 415—429
`
`
`
`
`
`
`93-85 12i08t$04.00 + 0
`
`Copyright © 1998, American Society for Microbiology. All Rights Reserved.
`
`
`
`
`
`
`
`
`
`
`
`
`
`Vol. 11. No. 3
`
`
`
`
`
`
`
`
`Onychomycosis: Pathogenesis, Diagnosis,
`
`
`and Management
`BONI E. ELEWSKI‘
`
`
`
`
`Department ofDermnroioy, Universin Hospitals of Cleveland,
`
`
`
`
`
`
`Case Westem Reserve Universitv, Cleveland. Ohio
`
`
`
`
`
`
`
`
`
`
`
`u...."noun-nun-uuu-uuuuouuu
`
`"no-noun. «nun...
`
`
`
`
`
`
`ONYCHOMYCOSIS................. ..
`
`Definition and Clinical Impact
`
`
`
`
`Epidemiology and Risk Factors
`
`
`
`
`DERMATOI’HYTES AND ONYCHOMYCOSI
`
`
`CLINICAL
`
`
`..
`..
`ANATOMY OF THE NAIL
`
`
`
`
`CLASSIFICATION OF ONYCHOMYCOSIS
`
`
`Distal Subungual Onychomycosis
`
`
`
`Proximal Snbungual Onychomycosis
`
`
`White Superficial Onychomycosis
`
`
`
`
`
`
`
`
`Total Dystrophic Onychomycosis ..
`
`
`
`DIAGNOSIS OF ONYCHOMYCOSI
`
`
`
`Difl'erential Diagnosis.......................... ..
`
`
`Collecting the Nail
`
`
`
`
`Distal subungual onychomycosis
`
`
`
`Proximal subungual onychomycosi
`
`
`White superficial onychomycosis
`
`
`
`Candida onychornycosis..
`
`
`Specimen Analysis
`
`
`ANTIFUNGAL SUSCEPTIBILITY
`
`
`
`ANTIMYCOTIC AGENTS USED TO TREAT ONYCHOMYCOSIS..
`
`
`
`
`
`
`Limitations of Traditional Antifungal Agents
`
`
`
`
`
`Griseofulvin
`..
`
`
`
`
`
`
`«noun-nu
`
`nun.
`
`no nu a nu o u a "to u
`
`a - u- . nu nu us a n.
`
`
`Advantages of Newer Antifungal
`
`
`
`Fluconazole
`..
`
`Itraconazole
`
`
`
`
`
`
`.
`
`
`
`ANTIFUNGAL
`
`
`Comparative Trials of Antifungal Agents.......
`
`
`
`
`
`
`
`
`
`
`Recent years. however, have witnessed the development of a
`
`
`
`
`
`.......415
`
`
`.......416
`
`
`....416
`
`
`
`
`.. 416
`
`
`
`
`
`
`
`
`..........4l8
`
`
`.......418
`
`
`""419
`
`
`
`
`...419
`
`
`...41 9
`
`
`
`
`
`
`..........42[l
`
`
`
`
`...42|J
`
`
`...42l]
`
`
`...421
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`".427
`
`
`
`
`....427
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Clinical Management of Treated Patients
`
`
`
`
`
`Educating Patients about Their Role in Treatment
`
`
`
`
`
`
`
`
`
`
`
`
`
`INTRODUCTION
`
`
`
`
`
`
`
`
`
`
`
`
`Most cutaneous infections are the work ofthe homogeneous
`
`
`
`
`
`
`
`
`group of keratinophilic fungi known as dcrmatophytes. The
`
`
`
`
`
`
`
`
`
`dcrmatophyte Trichophyron moi-um is the major cause of tinea
`
`
`
`
`
`
`
`
`
`pedis and onychomycosis {8). After originating in West Africa.
`Southeast Asia. Indonesia. and Northern Australia, 1“". mbmm
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`spread to Europe and North and South America in the late
`
`
`
`
`
`
`
`
`
`
`
`
`19th and earl}.r 201h centuries, where it found a niche within a
`
`" Mailing address: Department of Dermatology. University Hospi-
`
`
`
`
`
`
`
`tals of Cleveland.
`lll[)(l Euclid Ave. Cleveland, OH 44106—5028.
`
`
`
`
`
`
`
`
`Phone: [216) 844-3177. Fax: (216) 844-8093. E-mail: BEELEWSKI
`
`
`
`
`
`
`
`@AOL.COM.
`
`
`
`
`
`Page 3 of 17
`
`
`
`
`
`
`
`
`
`
`recently shod populace (8). Subsequent 20th century develop-
`
`
`
`
`
`
`
`
`ments including wars. the modern health movement and the
`associated use of occlusive footwear and locker rooms, and
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`migration of people since the invention of the jumbo jet, pro-
`
`
`
`
`
`
`
`
`moted an increased incidence of tinea pedis and onychomyco-
`sis (8).
`
`
`
`
`
`
`
`
`
`Dermatophytoses of the fingernails and toenails, in contrast
`to those at other body sites, are particularly difiicult to eradi—
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`cate with drug treatment. This is the consequence of factors
`
`
`
`
`
`
`
`
`intrinsic to the nail—the hard, protective nail plate, sequestra-
`tion of pathogens between the nail bed and plate, and slow
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`growth of the nail—as well as of the relatively poor efficacy of
`
`
`
`
`the early pharmacologie agents.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Page 3 of 17
`
`

`

`CLIN. M1010 ,,
`
`.
`
`,
`
`‘
`
`who presented for onyehomyeosis were excluded) (21); ,
`figures are comparable to those for the general Finnish
`lation (8.4%) (40). Several studies have shown that
`It”
`alence of onyehomyeosis increases with age. For examp
`of the 200 Finnish subjects who were younger than 3 ,
`liad onyehomyeosis but almost 24% of those aged 70
`of“
`older had the disorder. Similarly, 28.1% ofthe member; )1 ~
`Ohio cohort aged 60 years or older were culture posi
`onyehomyeosis, versus LI and 2.9% for those aged 10“.
`years and I9 to 30 years. respectively (27). Reasons
`(-
`age-related increase in onyehomyeosis may include . I .
`ripheral circulation, diabetes, repeated nail trauma. lo 5
`posure to pathogenic fungi, suboptimal immune functi
`activity, or the inability to cut the toenails or 'maintain..
`foot care (22. 27, 55).
`As is the case among adults. prevalence rates for M;
`mycosis among children are quite variable: a recent r ‘
`'
`studies of the subject in several countries outside North 2'. :.
`ica lists prevalence rates varying from 0% (United .7
`Wales. and Finland) to 2.6% (Guatemala) (38). To learn“
`about
`the prevalence of onyehomyeosis among chil 6.
`North America, a prospective survey was conducted of 4‘
`young (5 18 years) patients and family members in Canada ‘
`the United States. Subjects’ tiails were examined for si
`onyehomyeosis and sampled for direct microscopy and en!
`Onychomycosis was diagnosed in 11 children (10 with a
`toenails, and l with affected fingernails), indicating a n
`lence of 0.44%; however, 7 of these children had been ref 1
`for treatment of onychomycosis or tinea pedis. Thus, the _ _'.
`alcnec of onychomycosis in children with primary 3-.
`other than onyehomyeosis or tinea pedis was 4 of 2 Hr.
`0.16% (37). The reasons for this 30-fold decrease in the v
`alcnee of onyehomyeosis in children relative to adults
`include reduced exposure to fungus because less time is ~-
`w
`in environments containing pathogens; faster nail
`1:
`smaller nail surface for invasion; and lower prevalence of -~._~’
`pedis (37).
`Contact with the source of the infection constitutes a
`factor; for example, Tn'chophyton venucosum commonly
`fccts the faces of farmers who lean against their cows as n..-
`milk them (64). There is no doubt that several faCtors uni
`‘
`to modern life have resulted in an increased prevalence}-
`onyehomyeosis. These include the wearing of shoes. p ,
`larly fashionably tight, high-heeled shoes; the increased use-
`large numbers of people of damp spaces such as locker r .
`and gymnasiums; the declining health of the aging Amati
`population, and the increased number of immunocom r
`mised patients through disease (e.g.. HIV infection) or
`_
`peutic agents (e.g., immunosuppressive therapies assoc“ '
`with cancer or posttransplantation care. and the extensive .
`of broad-spectrum antibiotics) (25). Other factors that incre
`the risk of onyehomyeosis are direct trauma to the nail. inf:l
`ing that resulting from certain tic disorders (e.g., nail bit!!!
`
`
`
`'
`
`‘
`
`\
`
`DERMATOPHYTES AND ONYCHOMYCOSIS
`
`The term “dermatophytosis” is used to describe infection "
`members of the genera Microsporum, Trichophyton, and E ’
`‘
`demiophyton. The species that most often cause onyehomy N -'
`in North America and parts of Europe are T. rubrum. T.
`tagrophytes, and Epidermophyton floceosum: the first two 5 "
`eies are much more often implicated than E. floccm'um (58 -
`Infections of the skin, nail. and hair by nondermatophyfl?
`tnolds such as Scylulidium and Scopulafiopsis are termed “dare
`matomycoses." Dermatophytes account for most (900/1) 08'
`of onyehomyeosis of the toenails and at least 50% of finge
`
`4 l6
`
`ELEWSKI
`
`new generation of antifungal drugs that produce impressive,
`long-lasting cure rates with shorter treatment times and better
`safety profiles than ketoconazole and griseofulvin. In this pa-
`per, current knowledge of the pathogenesis. diagnosis, and
`management of onychomycosis with these new agents is re-
`viewed and evaluated.
`
`ONYCHOMYCOSIS
`
`Definition and Clinical Impact
`
`“Onychomycosis” traditionally referred to a nondermato-
`phytic infection of the nail but is now used as a general term to
`denote any fungal nail infection (63) (tinea unguium specifi-
`cally describes a dermatophytic invasion of the nail plate). In
`spite of the clearly diseased appearance associated with this
`condition, onyehomyeosis is all too often regarded as merely a
`cosmetic problem of relatively minor importance that is hardly
`worth the effort to resolve. This belief may have been sup‘
`ported by the adverse effects and long dosing courses associ-
`ated with some of the earlier antifungal agents.
`In fact, onyehomyeosis can have significant negative effects
`on patients' emotional. social, and occupational functioning
`and can, in addition, consume a sizable proportion of health
`care dollars. Affected patients may experience embarrassment
`in social and work situations. where they feel blighted or un-
`clean. unwilling to allow their hands or feet to be seen. Patients
`may fear that they will transmit their infection to fartiin mem-
`bers. friends, Or coworkers, fears that can lead to diminished
`self-esteem and the avoidance of close relationships (55). Em-
`ployment suffers if employers are reluctant to hire individuals
`with abnormal nails, particularly forjobs such as food handling
`or modelling or where interaction with the public is required.
`A more tangible barrier to work success is the discomfort some
`patients experience that prevents them from carrying out work-
`related tasks such as prolonged standing, writing. or typing.
`Finally. onyehomyeosis can compel workers to take periodic
`sick leave. a problem even for treated patients if therapy is
`ineffective and/or long-lasting (55). This lack of success, in
`turn. can cause patients to feel discouraged or even to stop
`treatment. resigning themselves to permanent disfigurement
`and discomfort.
`
`Onychomycosis in immunocompromised patients, such as
`thme infected with human immunodeficiency virus (HIV), can
`pose a more serious health problem (55). Not only does the
`difiicult-to-treat infection serve as a constant reminder to the
`patient of his or her own deteriorated condition, but the pos-
`sibility exists of transfer of a very high titer of fungal pathogens
`to another person (55).
`
`Epidemiology and Risk Factors
`
`Dermatophytoses of the stratum corneum, hair, and nails
`are common, whereas infection of the dermis and subcutane-
`ous tissue by these agents is rare (64). Although dermatophytic
`infections are rarely life-threatening. their high incidence and
`prevalence and the associated morbidity (64) make them an
`important public health problem (1).
`Reports concerning the prevalence of onyehomyeosis are
`conflicting, with estimates ranging from 2 to 3% of the general
`US. population (27) to 13% of the male Finnish population
`(40).
`In a recent outpatient-based. cross-sectional survey of
`l,038 patients in a dermatology clinic waiting room in Cleve-
`land, Ohio, culture-confirmed dermatophyte onyehomyeosis
`was identified in 8.7% of the total population and in 6.5 and
`13.3% of the female and male subgroups. respectively (patients
`
`Page 4 of 17
`
`

`

`1998
`
`ONYCHOMYCOSIS
`
`417
`
`ponychium (Fig. 2). The infecting organism migrates proxi-
`
`fl». (31). Both demtatophytes and nondermatophytcs.
`1y Candida albicans, have been identified as sole etio-
`'
`ts of onychomycosis; however. the incidence of true
`5». actions (caused by dermatophytes plus nondermato-
`.5‘,
`. difficult to determine accurately (58) and is discussed
`below.
`"2 nnatophytcs are hyalinc scptatcd molds. The hyphac
`' mycelial organisms penetrate the stratum corneum of
`u and nails. The fungal cells manufacture keratinolytic
`which provide a means of entry into living cells (39).
`'ermatophytic species. which are basically soil sapro-
`'v-u at have acquired the ability to digest keratinous debris
`, have evolved to be capable of parasitizing keratinous
`j'of animals (1).
`families that include many of the known keratinolytic
`re the Anhmdermataceae and Onygenucmc in the phy-
`i r ycora (52). Members of these families are homoge-
`'th respect to appearance. physiology. taxonomy, anti-
`" , basic growth requirements.
`inl'ectivity, and the
`'
`they cause (52). Some, such as Microspomm (ants and
`w agrophylcs, have affinity for thc keratin of animals and
`whereas others are more specialized for a particular
`host (1).
`'bility with respect to the causative microorganism is
`"1 ' ographic and, within a given region. temporal. Because
`ms that cause clinically apparent disease tend to receive
`sin attention, pathogens whose invasion leads to hard-
`”w
`tdiscasc may bc present in a region but are less likely
`identified (1). By contrast, pathogens that cause readily
`« nt signs and symptoms are likely to be identified and
`. prevalence is likely to be noted. Thus, because reports
`5; the 1970s focused primarily on scalp infections, T. vio-
`was the most frequently isolated derrnatophyte during
`'t‘ ' aide in Europe (1 ) although 7‘. tmtsurans is the principal
`.-'I of tincu capitis in the United States and is emerging in
`pe.
`angcs over time within a region in the prevalence of
`5,3 v lar dermatophyte species also are common: although M.
`"ta‘nii and M. crmis were the most common causes of scalp
`'n in Western and Mediterranean Europe 50 to 100
`‘
`~ ago. tinca capitis has declined in incidence in Western
`7
`it -- and. when present. is caused primarily by M. canis (l)
`4 . vinlaccum ( l). Similarly, M. nudouinii and M. (unis were
`Imain causes of tinea capitis in the United States earlier in
`century; this role has been taken over by T tonsurans (l).
`' ther change that has occurred in recent years is the grow-
`» prevalence of dermatophytoscs of the foot (tinea pedis)
`‘ mils (tinca unguium) and decline in the prevalence of
`-u infections (1).
`
`CLINICAL TERMINOLOGY
`
`in many areas of medicine, the clinical terminology used
`(describe dennatophytic infections evolved in advance of
`.* rate knowledge about causation or pathophysiology. Tinea
`F gnawing worm") or "ringworm," a term derived from the
`-, ’arance of the characteristic skin lesions in this common
`Imatophytosis (64), affects the scalp (tinea capitis), glabrous
`’_«‘- (tinea corporis), groin (tinea cruris), nail (tinca unguium).
`7 ‘«
`(tinca pedis). beard (tinca barbac), and hand (tinca
`. 1 Hum). Other dermatophytoses are named for their appear-
`such as tinea favosa (favus. or honeycomb-like due to T.
`f‘ nleinii) or tinea imbricata (“composed of overlapping
`'
`“; ringworm due to T. concentricum).
`
`Page 5 of 17
`
`DORSAL VIEW
`
`Lateral
`"all
`
`.
`
`Nail plate
`Nail bed
`Lunula (distal matrix)
`Proxtmal nail told
`
`LATERAL VIEW
`
`Nail plate
`Cuticle
`Nail bed/ Mam
`
`I. The nail unit. Reprinted from reference 11 with permission of the
`FIG.
`publisher.
`
`ANATOMY OF THE NAIL
`
`A review of the anatomy of the nail unit and the process of
`nail growth may be helpful in understanding the pathogenesis
`of dermatophytic fungi in the nail unit. A diagram of the nail
`unit is presented in Figure I (11). It consists of the following
`structures: proximal and lateral folds. cuticle. matrix. nail plate
`(commonly called the nail), nail bed. and hyponychium. The.
`cuticle is the horny layer of the proximal nail fold; it consists of
`modified stratum corneum and protects the nail matrix from
`infection (12). The nail matrix is the growth center ofthe nail.
`As the nail grows. cells of the nail matrix divide, differentiate.
`and kcratinizc and are incorporated into the nail plate. The
`distal. visible part of the matrix looks like a "half moon” and is
`called the lunula. The matrix extends approximately 5 mm
`proximally beneath the proximal nail fold (l2). The nail plate
`is the largest structure of the nail unit and grows by sliding
`forward over the nail bed, whereupon the distal end becomes
`free of the nail bed (44). The hyponychium, the most distal
`component in the nail bed.
`is composed of epidermis that
`includes a granular layer similar to that seen in plantar and
`volar surfaces (12). Fingcrnails grow at a rate of 2 to 3 mm per
`month. and toenails grow at a rate of 1 mm per month. There-
`fore. it takes about 0 months to replace a fingernail and be-
`tween 12 and 18 months to replace a toenail (12). This rate of
`growth is often decreased in the presence of peripheral vascu-
`lar disease and onychomycosis and in the elderly (12).
`
`CLASSIFICATION OF ONYCHOMYCOSIS
`
`Four types of onychomycosis. charactcrizcd according to
`clinical presentation and the route of invasion, are recognized.
`
`Distal Subungual Onychomycosis
`
`Distal subungual onychomycosis (D50) is the most common
`form of onychomycosis. It is characterized by invasion of the
`nail bed and underside of the nail plate beginning at the hy-
`
`

`

`

`

`
`
`Candida Infections of the Nail
`
`321/ nail infections occur in patients with chronic mu-
`. us candidiasis. and are caused by C. albicans (3). The
`:invades the entire nail plate. Candida spp. may cause
`.a
`u omes. including onycholysis and paronychia. These
`‘qu more commonly in women than in men (3) and
`'
`the middle linger, which may come into contact
`:1 i
`I organisms that reside in the intestine or vagina
`‘ In onychomycosis can therefore be divided into
`f oral categories. (i) Infection beginning as a paro-
`‘fection of the structures surrounding the nail; also
`“whitlow"). the most common type of Candida ony-
`...:
`(54), first appears as an cdcmatous. reddencd pad
`mg the nail plate. Invasion by Candida spp.. unlike
`‘hytic invasion. penetrates the nail plate only second-
`.u r it has attacked the soft tissue around the nail (12).
`.t ection of the nail matrix occurs.
`transverse depres-
`t: au’s lines) may appear in the nail plate. which be-
`unvex. irregular. and rough and. ultimately. dystrophic
`
`5 tients with chronic mucocutaneous candidiasis are at
`
`the second type of Candida onychomycosis. called
`.-
`‘T'r granuloma. which accounts for fewer than 1% of
`'<-. ycosis cases (12, 54. 66). This condition is seen in
`. it mpromised patients and involves direct invasion of
`'j“ plate (30). The organism invades the nail plate directly
`affect
`the entire thickness of the nail. resulting,
`in
`‘1» d cases.
`in swelling of the proximal and lateral nail
`" til the digit develops a pseudo-clubbing or "chicken
`'_'»
`'ck” appearance (54).
`it Finally, Candida onycholysis can occur when the nail
`} has separated from the nail bed. This form is more
`on on the hands than the feet
`(3). Distal subungual
`_ eratosis can be seen as a yellowish gray mass lifts off the
`late. The lesion resembles that seen in patients with DSO
`
`Total Dy'slmphic Onychomycosis
`
`tal dystrophic onychomycosis is used to describe end-
`nail disease. although some clinicians consider it a dis-
`'v2 subtype. It may be the end result ofany of the four main
`7" ms of onychomycosis. The entire nail unit becomes thick
`1 dystrophic (65).
`
`DIAGNOSIS OF ONYCHOMYCOSIS
`
`i
`
`‘ e clinical presentation of dystrophic nails should alert the
`' ian to the possibility of onychomycosis; however, because
`' i cause only about half of all nail dystrophies (30). the use
`appropriate diagnostic techniques including direct micros-
`i.- and fungal culture is important to ensure correct diagno-
`and treatment. The clinical appearance of the nail and the
`'ent's history will help differentiate fungal from nonfungal
`logics of nail dystrophies. For example. predisposing fac-
`‘t
`for onychomycosis include diabetes mellitus. older age.
`j“ rhidrosis. onychogryphosis. nail trauma. poor peripheral
`"- ulation. and immunosuppression (l2). In the presence of
`bungual hyperkeratosis, yellow-brown discoloration. and on-
`holysis, onychomycosis is likely to be present. If the patient
`~
`21 history of tinea pcdis. particularly moccasin type. the case
`*t
`.I this diagnosis is even stronger (l2).
`Page 7 of 17
`
`()NYCI-IOMYCOSIS
`
`41‘)
`
`FIG. 5. Psoriasis affecting the nail. Courtesy of C. R. Daniel Ill.
`
`Differential Diagnosis
`
`(‘arc should be taken to correctly identify signs and symp-
`toms of other diseases that clinically mimic onychomyCosis.
`These include psoriasis (the most common such disorder).
`lichen planus. bacterial
`infections. contact dermatitis.
`trau-
`inatic onycliodystt‘opltics, pacltyonycliia cottgenita. nail bed tu-
`mors. yellow~nail syndrome (rare). and idiopathic onycholysis.
`When psoriasis all'ects the nails.
`it
`is usually also present at
`other skin sites; however. in some cases nail involvement is the
`only sign (6). When psoriasis alfccts the nails.
`it can produce
`onycholysis resembling that associated with 050 (Fig. 5). A
`diagnosis of psoriasis is supported by the presence of line
`pitting on the nail surface. the small salmon-colored “oil drop"
`sign of onycholysis that
`is not seen in onychomycosis. and
`fingernail involvement of both hands (28).
`Approximately um of patients with lichen planus have ab-
`normal nails. "'l‘wenty-nail" dystrophy is ti condition of un-
`known cause. Onychorrhcxis (exaggerated longitudinal ridg-
`ing) and “angel wing deformity." in which the central portion
`of the nail is raised and the lateral portion is depressed (28).
`are manifestations of lichen planus. A patient with 20 dystro-
`phic nails is unlikely to have onychomycosis. Contact derma-
`titis occasionally resembles onychomycosis. The correct diag-
`nosis is facilitated by knowledge of kn0wn contactants and the
`presence of contact dermatitis elsewhere on the body.
`Finally. repeated nail trauma can cause distal onycholysis.
`leading to colonization of the affected space by microorgan-
`isms that produce pigmentation of the area. It the onycholytic
`nail is clipped to allow examination of the nail bed. [he latter
`will be normal if the symptoms are caused by trauma rather
`than onychomycosis. Nail products containing formaldehyde
`may also cause onycholysis.
`In this situation.
`the nails may
`become yellow and all exposed nails are affected. A habit tic.
`often manifesting as a median furrow or depression in the
`middle of the nail. developed from picking at the nail cuticle.
`may also cause abnormalities of the nail.
`
`

`

`

`

`. 998
`
`ONYCHOMYCOSIS
`
`42]
`
`
`
`9 half of all specimens taken from onychomycotic nails
`'cld a pathogen in culture. In onychomycosis, direct
`L. is the most efficient screening technique (26, 63).
`g: . cimen can be mounted in a solution of 20 to 25%
`' NaOH mixed with 5% glycerol. heated to emulsify
`h at 51 to 54°C). and examined under X40 magnifi-
`tAn alternative formulation consists of 20% KOH and
`'ethyl sulfoxide (63). The specimen may be counter-
`'with chitin-specific Chlorazol black E to accentuate
`‘ that are present; this is of particular value if the num-
`t. al elements is small. This stain is especially useful
`1- it does not stain likely contaminants such as cotton or
`-- fibers. which can help prevent false-positive identifica-
`ju ). Parker blue-black ink also can be added to the KOH
`': tion to improve visualization, but this stain is not chitin
`
`'
`
`7‘ re is the only method by which the causative microor-
`can be identified. Caution should be used in analyzing
`results, because nails are nonsterile and fungal and
`4‘
`'i: contaminants may obscure the nail pathogen (63).
`ens should be plated on two different media: a primary
`‘m that is selective against most nondermatophytic molds
`teria, and a secondary medium that allows such growth.
`it admide inhibits the growth of nondermatophytes and is
`m rated into media such as dermatophyte test medium or
`,1: ud peptone-glucose agar (Emmons' modification) with
`_:t ximide, available under a variety of names (Mycobiotic
`'-' Laboratories, Detroit, Mich.) and Mycosel [BBL Cock-
`i Md.]) (63). Cyclohcximidc-frcc media that are com-
`; used include Sabouraud’s glucose agar. Littman’s oxgall
`~I- u and inhibitory mold agar (Sabouraud‘s glucose agar
`'7 the addition of antibiotics) (25). if growth occurs on both
`-: of media, the infective agent is probably a dermatophyte,
`growth only on the cycloheximide-free medium indi-
`. that the infective agent may be a nondermatophyte such
`pulariopsis brevicaulis, Scytalidium dimidiatum. or Scy-
`hyalinum.
`i ever. growth of a nondermatophyte alone from a spec-
`that has tested positive for fungi on direct microscopy
`: not prove conclusively that the infective agent is a non-
`1- tophyte (63). The last three decades have seen unequiv-
`-," documentation of the role of nondermatophytes as causal
`-* in onychomycosis (59). The most common yeast that is
`_lved is C. albicans (58). Of the nondermatophytic filamen-
`~: fungi, agents implicated in onychomycosis include mem-
`_ of Scapulariopsis (particularly S. brevicault's) and Scy-
`' m (the two most common genera), which are both
`6‘ ht to digest keratin in vivo, as well as members of the
`A fit Allemaria, Aspelgillus, Acremom’um, and Fusarium (59).
`.24 y of these nondermatophyte fungi invade the nail unit
`1'
`fly and cause WSO. Other nondermatophytic fungi that
`7 cause onychomycosis include Onychocola canadertsis, Pyre-
`?- eta tmguierominis, and Bohyodiplodia Ihcobromac (Ta-
`« l) (57, S9).
`1 Part of the difficulty in evaluating the role of nondermato-
`7 c fungi cultured from the nail arises because the same
`in i that can be laboratory contaminants are also occasionally
`'1 nd to be pathogens (58). Reference laboratories should
`*1 Vide data on whether the isolated fungus was a likely patho-
`i n or an unlikely one. All dermatophytes should be consid-
`ed pathogens. All other isolated organisms are probably lab-
`i atory contaminants unless KOH or microscopy indicates
`'cy have the atypical frondlike hyphae associated with non-
`ermatophyte molds or if the same organism is repeatedly
`latcd. Potential pathogens associated with onychomycosis
`‘2 e listed in Table l.
`
`Page 9 of 17
`
`TABLE I. Major causes of onychomycosis
`
`Dcrmatophytc fungi
`Epidemmphymn floccnsum
`Tfichophylon menmgmphylcs
`Tfichophyton mbmm
`
`Nondcrmatophyte fungi
`Acremom'um
`Altcmaria species
`Aspelgillus species
`Borryodiplodia thcnbmmac
`Fusarium species
`Onycochola canadcnsis
`I’yrruoclmcm ultguis-Iiuminix
`Scyialidium dimidiamm scopulariopsis species
`Scytalidium hyalimum
`
`Yeast
`Candida albicans
`
`To increase the predictive power of a diagnosis of nonder-
`matophytic invasion of a nail, Summerbell (58) suggested that
`nonfilamentous nondermatophytes identified in nail tissue be
`categorized as one of the following: contaminant
`(species
`growing in culture from dormant propagules on the nails):
`normal mammalian surface commensal organism; transient sa-
`probic colonizer (colonizer of accessible surface molecules but
`noninvasive); persistent secondary colonizer (colonizer of ma-
`terial infected by a dermatophyte but incapable of remaining
`after the dermatophyte is eliminated): sueccssional
`invader
`(species that can cause infection after gaining entry into a nail
`via the disruption caused by a primary pathogen); or primary
`invader (able to infect and cause onychomycosis in a previously
`uncolonized nail). Such an analysis has the value of identifying
`for treatment only nondermatophytic infections that are truly
`mvaswc.
`
`As an additional confirmatory technique, definitive identifi-
`cation of nondermatophytic invasion in nails may require the
`isolation of the agent from successive specimens from the
`infected region (03). If the infective pathogen is a dermato-
`phyte, subsequent cultures will most probably grow out the
`dermatophyte itself, a second contaminant unrelated to the
`first, or no growth at all. Some investigators believe that claims
`of an increasing proportion of mixed infections in onychomy-
`cosis are exaggerated and have gone so far as to state that
`nondermatophyte molds and yeasts are usually contaminants
`secondary to dermatophyte onychomycosis and that their pres-
`ence need not affect treatment outcome (31).
`
`ANTIFUNGAL SUSCEPTIBILITY TESTING
`
`Part of the diagnosis and treatment strategy might include
`fungal susceptibility testing. Susceptibility testing for antifun-
`gal drugs was virtually unknown in the 19803 but is now the
`focus of interest of the Subcommittee for Antifu

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket